Eli Lilly and Company (LLY)
-NYSE 54.89 
0.03(0.05%) 3:11PM EDT - Nasdaq Real Time Price
| Prev Close: | 54.92 |
|---|
| Open: | 54.67 |
|---|
| Bid: | 54.85 x 800 |
|---|
| Ask: | 54.86 x 400 |
|---|
| 1y Target Est: | 56.41 |
|---|
| Beta: | 0.42 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 54.51 - 55.29 |
|---|
| 52wk Range: | 39.93 - 58.40 |
|---|
| Volume: | 2,672,912 |
|---|
| Avg Vol (3m): | 5,092,360 |
|---|
| Market Cap: | 59.51B |
|---|
| P/E (ttm): | 13.18 |
|---|
| EPS (ttm): | 4.16 |
|---|
| Div & Yield: | 1.96 (3.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The Coming Diabetes Warsat Motley Fool(Thu 11:48AM EDT)
- Socially Minded Seniors Keep Co-Op Spirit Alive In Cambridgeat Forbes(Thu 11:20AM EDT)
- 4 Big Drug Companies With Big Juicy Yieldsat Motley Fool(Wed, May 22)
- Jim Simons' top stock holdingsat MarketWatch(Wed, May 22)
- Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Failat Bloomberg(Wed, May 22)
- The 5 Highest-Paying Dividend Stocks in Big Pharmaat Motley Fool(Wed, May 22)
- 6 Ways You Can Profit From Molecular Diagnosticsat Seeking Alpha(Wed, May 22)
- Do Major Drug Manufacturers Have Room to Grow?at Motley Fool(Wed, May 22)
- Pricing A Highly Probable Takeover Of MannKindat Seeking Alpha(Wed, May 22)
- The Surprising Link Between ADHD and Obesityat Motley Fool(Tue, May 21)
- The Top 3 Diseases Caused by Stressat Motley Fool(Tue, May 21)
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY)at TheStreet(Tue, May 21)
- ‘Love Hormone’ Promises Safer Births After Pfizer Flopat Bloomberg(Mon, May 20)
- Big Pharma's Biggest Grudge Matchat Motley Fool(Mon, May 20)
- Vitamins That Cost Pennies a Day Seen Delaying Dementiaat Bloomberg(Mon, May 20)
Key Statistics
| Forward P/E (1 yr): | 20.10 |
|---|
| P/S (ttm): | 2.63 |
|---|
| Ex-Dividend Date: | 14-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.91 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.00 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The companys neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I...
View More